Dermal Hypersensitivity: Immunologic Principles and Current Methods of Assessment.
Authors
Henningsen GM
Source
Dermal and Ocular Toxicology: Fundamentals and Methods 1991:153-192
Link
NIOSHTIC No.
00211147
Abstract
Immunologic principles and methods for investigating dermal hypersensitivity were reviewed. The epidemiological aspects of chemically allergic contact dermatitis were summarized. Estimates by various governmental agencies and groups have indicated that skin problems account for up to 28% of the reported illnesses. NIOSH considers dermatological conditions to be one of the ten leading occupational diseases. Allergic contact dermatitis has been estimated to account for 20 to 25% of all cases of occupational dermatitis. The five most common causes of allergic contact dermatitis in the United States have been reported to be plant resins, nickel (7440020), p-phenylenediamine (106503), rubber chemicals, and ethylenediamine (107153). The skin has been characterized as a secondary immune organ in terms of innate resistance to infections and acquired specific immunity to foreign antigens. Langerhans cells are thought to be an important component of the skin immune system as they process antigens in the skin that induce humoral immunoglobulin-A, cutaneous cell mediated immunity, or allergic contact dermatitis. The immunological functions of the skin as they pertain to disease resistance and immunopathology were considered. Individual variations in the expression of allergic contact dermatitis were described. The immunologic basis of dermal hypersensitivity was considered. The mechanisms of allergic contact dermatitis and atopic dermatitis were discussed. The effects of immune system dysfunction induced by biomolecules, drugs, chemicals, and immunomodulatory physical agents and diseases on dermal hypersensitivity were considered. Current methods for assessing dermal hypersensitivity were reviewed. In-vitro screening methods for assessing dermal hypersensitivity were summarized.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.